A detailed history of Fundamentun, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fundamentun, LLC holds 48,387 shares of NVO stock, worth $6.92 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
48,387
Previous 23,812 103.2%
Holding current value
$6.92 Million
Previous $2.46 Million 152.21%
% of portfolio
0.65%
Previous 0.31%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $2.51 Million - $3.34 Million
24,575 Added 103.2%
48,387 $6.21 Million
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $2.09 Million - $2.51 Million
23,812 New
23,812 $2.46 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fundamentun, LLC Portfolio

Follow Fundamentun, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.